The dense LDL phenotype: Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men

Diabetes Care

Volumn 19, Issue 6, 1996, Pages 629-637

  Tchernof, André ^a   Lamarche, Benoît ^a   Prud'homme, Denis ^a   Nadeau, André ^a   Moorjani, Sital ^a   Labrie, Fernand ^a   Lupien, Paul J ^a   Després, Jean Pierre ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; GLUCOSE TOLERANCE; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PHENOTYPE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0029893909     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.6.629     Document Type: Article

References (52)

1. Krauss RM, Burke DJ: Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 23:97-104, 1982
2. Nichols AV, Krauss RM, Musliner TA: Nondenaturing polyacrylamide gradient gel electrophoresis. In Methods in Enzymology: Lipoprotein Structure and Molecular Biology. Vol. 128. Sergrest JP, Albers JJ, Eds. Orlando, FL, Academic, 1986, p. 417-431
3. McNamara J, Campos H, Ordovas JM, Peterson J, Wilson PWF, Schaefer EJ: The effect of gender, age, and lipid status on low density lipoprotein subfraction distribution: results of the Framingham offspring study. Arteriosclerosis 7:483-490, 1987
4. Austin MA, Breslow JL, Hennekens CH, Buring JL, Willet WS, Krauss RM: Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260: 1917-1921, 1988
5. Austin MA, King MC, Vranizan KM, Newman B, Krauss RM: Inheritance of low density lipoprotein subclass patterns: results of complex segregation analysis. Am J Hum Genet 43:838-846, 1988
6. Campos H, Blijlevens E, McNamara JR, Ordovas JM, Posner BM, Wilson PWF, Castelli WP, Schaefer EJ: LDL particle size distribution, results from the Framingham offspring study. Arteriosclerosis 12:1410-1419, 1992
7. Crouse JR, Parks JS, Schey HM: Studies of low density lipoprotein molecular weight in human beings with coronary artery disease. J Lipid Res 26:566-574, 1985
8. Fisher WR: Heterogeneity of plasma low density lipoprotein manifestation of the physiologic phenomenon in man. Metabolism 32:283-291, 1983
9. Campos H, Genest JJ, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, Wilson PWF, Schaefer EJ: Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb 12:187-195, 1992
10. McNamara JR, Jenner JL, Li Z, Wilson PWF, Schaefer EJ: Change in LDL particle size is associated with change in plasma triglyceride concentration. Arterioscler Thromb 12:1284-1290, 1992
11. Austin MA, King MC, Vranizan KM, Krauss RM: Atherogenic lipoprotein phenotype, a proposed genetic marker for coronary heart disease. Circulation 82: 495-506, 1990
12. Swinkles DW, Demacker PNM, Hendriks JCM, Laar AV: Low density lipoprotein subfractions and relationship to other risk factors for coronary artery disease in healthy individuals. Arterioscler Thromb 9:604-613, 1989
13. Zhao SP, Verhoven MH, Vink J, Hollar L, Van Der Laarse A, De Knijff P, Van T, Hooft FM: Relationship between apolipoprotein E and low density lipoprotein particle size. Atherosclerosis 102:147-154, 1993
14. Austin MA: Genetic epidemiology of low-density lipoprotein subclass phenotypes. Ann Med 6:477-481, 1992
15. Reaven GM, Chen YDI, Jeppesen J, Maheux P, Krauss RM: Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J Clin Invest 92:141-146, 1993
16. Ducimetière P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G: Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 19:205-210, 1980
17. Fontbonne A, Eschwege E, Cambien F, Richard JL, Ducimetière P, Thibult N, Warnet JM, Claude JR, Rosselin GE: Hypertriglyceridemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes: results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 32:300-304, 1989
18. Pyörälä K: Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 2:131-141, 1979
19. Welborn TA, Wearne K: Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentration. Diabetes Care 2:154-160, 1979
20. Assmann G, Schulte H: Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Am J Cardiol 70:733-737, 1992
21. Manninen V, Tenkanen L, Koskinen P, Huttunen JK, Mänttäri M, Heinonen OP, Frick MH: Joint effects of serum triglyceride and LDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study: implications for treatment. Circulation 85:37-45, 1992
22. Després JP, Moorjani S, Lupien PJ, Bouchard C: Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arterioscler Thromb 10:497-511, 1990
23. Pouliot MC, Després JP, Nadeau A, Moorjani S, Prud'homme D, Lupien PJ, Tremblay A, Bouchard C: Visceral obesity in men: associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 41:826-834, 1992
24. Lamarche B, Després JP, Pouliot M-C, Prud'homme D, Moorjani S, Lupien PJ, Nadeau A, Tremblay A, Bouchard C: Metabolic heterogeneity associated with high plasma triglyceride or low HDL cholesterol levels in men. Arterioscler Thromb 13:33-40, 1993
25. Després JP: Dyslipidemia and Obesity. Baillères's Clin Endocrinol Metab 8:629-659, 1994
26. Després JP: Abdominal obesity as important component of insulin-resistance syndrome. Nutrition 9:452-459, 1993
27. Behnke AR, Wilmore JH: Evaluation and Regulation of Body Build and Composition. Englewood Cliffs, NJ, Prentice-Hall, 1974, p. 20-37
28. Meneely GR, Kaltreider NL: Volume of the lung determined by helium dilution. J Clin Invest 28:129-139, 1949
29. Sin WE: The gross composition of the body. Adv Biol Med Phys 4:239-280, 1956
30. Ferland M, Després JP, Tremblay A, Pinault S, Nadeau A, Moorjani S, Lupien PJ, Thériault G, Bouchard C: Assessment of adipose tissue distribution by computed axial tomography in obese women: association with body density and anthropometric measurements. Br J Nutr 61: 139-148, 1989
31. Després JP, Prud'homme D, Pouliot MC, Tremblay A, Bouchard C: Estimation of deep abdominal adipose-tissue accumulation from simple anthropometric measurements in men. Am J Clin Nutr 54:471-477, 1991
32. Desbuquois B, Aurbach GD: Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab 37:732-738, 1971
33. Richterich R, Dauwalder H: Zur bestimmung der plasmaglukosekonzentration mit der exokinase-glucose-6-phosphatdehydrogenase-methode. Schweiz Med Wochenschr 101:615-618, 1971
34. Fossati P, Prencipe L: Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 28:2077-2080, 1982
35. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC: Enzymatic determination of total serum cholesterol. Clin Chem 20:470-475, 1974
36. Havel RJ, Eder H, Bragdon HF: The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34:1345-1353, 1955
37. Burstein M, Samaille J: Sur un dosage rapide du cholestérol lié aux β-lipoprotéines du sérum. Clin Chim Acta 34:1345-1353, 1960
38. Moorjani S, Dupont A, Labrie F, Lupien PJ, Brun D, Gagné C, Giguère M, Bélanger A: Increase in plasma high density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma. Metabolism 36:244-250, 1987
39. Laurell CB: Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 5:609-610, 1960
40. Canadian Consensus Conference on Cholesterol: Final report: Canadian Consensus Conference on the prevention of heart and vascular disease by altering serum cholesterol and lipoprotein risk factors. Can Med Assoc J 139 (Suppl. 11): 1-8, 1988
41. Williams PT, Krauss RM, Nichols AV, Vranizan KM, Wood PDS: Identifying the predominant peak diameter of high-density lipoproteins by electrophoresis. J Lipid Res 31:1131-1139, 1990
42. Tornvall P, Karpe F, Carlson LA, Hamsten A: Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction. Atherosclerosis 90:67-80, 1991
43. Austin MA, Brunzell JD, Fitch WL, Krauss RM: Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. Arterioscler Thromb 10:520-530, 1990
44. Després JP, Lamarche B: Effects of diet and physical activity on adiposity and body fat distribution: implications for the prevention of cardiovascular disease. Nutr Res Rev 6:137-159, 1993
45. Austin MA, Hokanson JE, Brunzell JD: Characterization of low-density lipoprotein subclasses: methodologic approaches and clinical relevance. Curr Opin Lipidol 5:395-403, 1994
46. Haffner SM, Mykkänen L, Valdez RA, Paidi M, Stern MP, Howard BV: LDL size and subclass pattern in a biethnic population. Arterioscler Thromb 13:1623-1630, 1993
47. Katzel LI, Krauss RM, Goldberg AP: Relations of plasma TG and HDL-C concentrations to body composition and plasma insulin levels are altered in men with small LDL particles. Arterioscler Thromb 14:1121-1128, 1994
48. Campos H, Bailey SM, Gussak LS, Sues X, Ordovas JM, Schaefer EJ: Relations of body habitus, fitness level, and cardiovascular risk factors including lipoproteins in a rural and urban Costa Rican population. Arterioscler Thromb 11:1077-1088, 1991
49. Feingold KR, Grunfeld C, Pang M, Doerrler W, Krauss RM: LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes. Arterioscler Thromb 12:1462-1502, 1992
50. Attia N, Durlach V, Paul JL, Soni T, Betoulle D, Girard-Globa A: Modulation of low density lipoprotein subclasses by alimentary lipemia in control and normotriglyceridemic non-insulin-dependent diabetic subjects. Atherosclerosis 113:197-209, 1995
51. Tan KCB, Cooper MB, Ling KLE, Griffin BA, Freedman DJ, Packard CJ, Shepherd J, Hales CN, Betteridge DJ: Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance. Atherosclerosis 113:273-287, 1995
52. Barakat HA, Carpenter JW, McLendon VD, Khazanie P, Leggett N, Heath J, Marks R: Influence of obesity, impaired glucose tolerance, and NlDDM on LDL structure and composition: possible link between hyperinsulinemia and atherosclerosis. Diabetes 39:1527-1533, 1990